These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 22544231)
1. Evidence that naturopathic therapy including Cordyceps sinensis prolongs survival of patients with hepatocellular carcinoma. Niwa Y; Matsuura H; Murakami M; Sato J; Hirai K; Sumi H Integr Cancer Ther; 2013 Jan; 12(1):50-68. PubMed ID: 22544231 [TBL] [Abstract][Full Text] [Related]
2. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529 [TBL] [Abstract][Full Text] [Related]
3. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S; J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371 [TBL] [Abstract][Full Text] [Related]
5. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma]. Wu J; Chen MH; Yang W; Wu W; Yan K Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Pinter M; Sieghart W; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Weissmann A; Kornek G; Matejka J; Stauber R; Buder R; Grünberger B; Schöniger-Hekele M; Müller C; Peck-Radosavljevic M Aliment Pharmacol Ther; 2011 Oct; 34(8):949-59. PubMed ID: 21883324 [TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Yuen MF; Chan AO; Wong BC; Hui CK; Ooi GC; Tso WK; Yuan HJ; Wong DK; Lai CL Am J Gastroenterol; 2003 May; 98(5):1181-5. PubMed ID: 12809846 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis. Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma. Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib. Kawaoka T; Aikata H; Murakami E; Nakahara T; Naeshiro N; Tanaka M; Honda Y; Miyaki D; Nagaoki Y; Takaki S; Hiramatsu A; Waki K; Takahashi S; Chayama K Oncology; 2012; 83(4):192-200. PubMed ID: 22890083 [TBL] [Abstract][Full Text] [Related]
13. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ; J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986 [TBL] [Abstract][Full Text] [Related]
14. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study]. Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013 [TBL] [Abstract][Full Text] [Related]
15. Application of DC beads in hepatocellular carcinoma: clinical and radiological results of a drug delivery device for transcatheter superselective arterial embolization. Sadick M; Haas S; Loehr M; Elshwi M; Singer MV; Brade J; Schoenberg SO; Diehl SJ Onkologie; 2010; 33(1-2):31-7. PubMed ID: 20164659 [TBL] [Abstract][Full Text] [Related]
16. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C. Shimoda M; Ghobrial RM; Carmody IC; Anselmo DM; Farmer DG; Yersiz H; Chen P; Dawson S; Durazo F; Han S; Goldstein LI; Saab S; Hiatt J; Busuttil RW Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585 [TBL] [Abstract][Full Text] [Related]
17. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort. Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438 [TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage. Plentz RR; Tillmann HL; Kubicka S; Bleck JS; Gebel M; Manns MP; Rudolph KL J Gastroenterol Hepatol; 2005 Sep; 20(9):1422-8. PubMed ID: 16105131 [TBL] [Abstract][Full Text] [Related]
19. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Helmberger T; Dogan S; Straub G; Schrader A; Jüngst C; Reiser M; Waggershauser T; Jakobs T; Hoffmann RT; Löhe F; Graeb C; Rau HG; Schauer R; Jauch KW; Caselmann WH; Göke B; Jüngst D Digestion; 2007; 75(2-3):104-12. PubMed ID: 17598962 [TBL] [Abstract][Full Text] [Related]
20. [Transarterial oil chemoembolization for hepatocellular carcinoma, in 100 cases]. Levy I; Verstandig A; Sasson T; Wolf D; Krichon I; Libson E; Levensart P; Papo O; Yurim O; Id A; Shouval D Harefuah; 2000 Jan; 138(2):89-93, 174. PubMed ID: 10883065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]